Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 7, 2004

View Archived Issues

Novel anti-H. pylori agents designed by Kotobuki scientists

ARS presents new prostaglandin FP receptor antagonists and their use

New lipid A analogues with immunosuppressant activity discovered at Sankyo

Pirfenidone effective against cirrhosis in vivo

Phase I study for SPRC-AB01

ConjuChem updates progress of DAC:GLP-1 development

OGX-011 reduces expression of a protein that promotes cell survival in prostate cancer

Nippon Shinyaku grants Ivax license to HMN-214

Good safety profile of the Taxus Express2 stent in clinical trials and postmarketing registries

Mallinckrodt claims radiolabeled D-amino acids for cancer diagnosis and therapy

Two novel series of HDAC inhibitors patented by Fujisawa

Enanta scientists present two new series of erythromycin-based antibiotics

Roche scientists describe new selective GlyT-1 inhibitors

FDA extends review period for MS-325

ZymoGenetics licenses rFactor XIII to Novo Nordisk

Squalamine granted fast track status for wet AMD

Phase I study for Hematide

Santarus launches Zegerid

Triton BioSystems licenses ING-1 antibody from Xoma

Stellar Biotechnologies awarded NCI grant for KLH development

OraDisc A approved for aphthous ulcers

Neupro submitted for approval in U.S., Europe for Parkinson's disease

Fast track designation for MDX-010 in metastatic melanoma

Antiinflammatory agent by Uriach promising for the treatment of IBD

The inhibition of ADAM metalloproteases may present a novel approach for treatment of cancer

Targeting skeletal metastases in prostate cancer

Regulation of tumor angiogenesis and cell survival by integrin-linked kinase

Germany marks first European launch of Raptiva

Infliximab reported to reduce pain associated with Crohn's disease

Degarelix reduces testosterone and PSA levels in prostate cancer patients

Sildenafil and antidepressants improve premature ejaculation

Therapeutic effects and quality of life improvements of darifenacin in overactive bladder patients

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...